Search

Your search keyword '"Traverse-Glehen A"' showing total 1,163 results

Search Constraints

Start Over You searched for: Author "Traverse-Glehen A" Remove constraint Author: "Traverse-Glehen A"
1,163 results on '"Traverse-Glehen A"'

Search Results

1. Anti-RGS8 paraneoplastic cerebellar ataxia is preferentially associated with a particular subtype of Hodgkin’s lymphoma

2. Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma

3. Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma

5. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748

7. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

10. Deep phenotyping of nodal T-cell lymphomas reveals immune alterations and therapeutic targets

11. Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study

12. The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients

13. Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5′RACE

14. High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma

15. Carbon footprint evaluation of routine anatomic pathology practices using eco-audit: Current status and mitigation strategies

16. Deciphering the spectrum of cutaneous lymphomas expressing TFH markers

17. Estimating the prevalence of Epstein–Barr virus in primary gastric lymphoma: a systematic review and meta-analysis

18. BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1

19. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

20. Clinical presentation, outcome, and prognostic markers in patients with intravascular large B‐cell lymphoma, a lymphoma study association (LYSA) retrospective study

21. P1243: FUNCTIONAL PRECISION ONCOLOGY FOR FOLLICULAR LYMPHOMA WITH PATIENT-DERIVED XENOGRAFT IN AVIAN EMBRYOS.

22. Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations

24. Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French Lymphopath network survey

26. Genetic and phenotypic attributes of splenic marginal zone lymphoma

27. Lymphomas associated with Epstein-Barr virus infection in 2020: Results from a large, unselected case series in France

28. Comprehensive genetic profiling reveals frequent alterations of driver genes on the X chromosome in extranodal NK/T-cell lymphoma

29. Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study

30. Hodgkin Lymphoma, Classical

31. New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas

32. Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study

33. Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified

34. Integrated spatial and multimodal single‐cell transcriptomics reveal patient‐dependent cell heterogeneity in splenic marginal zone lymphoma.

35. High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline

36. Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn’s Disease

39. Significance of Primary Melanoma Regression on Local Infiltrate and Outcome

40. Crystal‐storing histiocytosis and Bing‐Neel‐like syndrome revealing a small B‐cell lymphoma with plasmacytic differentiation, presumed to be a marginal zone lymphoma

45. Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation

50. Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH)

Catalog

Books, media, physical & digital resources